Skip to main content

Kim G Johnson

Associate Professor of Psychiatry and Behavioral Sciences
Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology
932 Morreene Road, Durham, NC 27514
932 Morreene Road, Durham, NC 27514

Current Appointments & Affiliations


Associate Professor of Psychiatry and Behavioral Sciences · 2025 - Present Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology, Psychiatry & Behavioral Sciences
Division Chief, Memory Disorders in the Department of Neurology · 2019 - Present Neurology, Clinical Science Departments
Associate Professor in Neurology · 2025 - Present Neurology, Behavioral Neurology, Neurology

In the News


Published January 22, 2025
Alzheimer's Clinic Provides Time and Hope
Published January 9, 2025
Dementia - Impact Not Just on Patients but on Families
Published September 11, 2024
New Alzheimer’s Medications Available at Duke What You Need to Know About Lecanemab and Donanemab

View All News

Recent Publications


Mapping the impact of age and APOE risk factors for late onset Alzheimer's disease on long range brain connections through multiscale bundle analysis.

Journal Article Brain Struct Funct · March 19, 2025 Alzheimer's disease currently has no cure and is usually detected too late for interventions to be effective. In this study we have focused on cognitively normal subjects to study the impact of risk factors on their long-range brain connections. To detect ... Full text Link to item Cite

Genetic and biomarker disclosure process in a memory and aging study.

Journal Article J Alzheimers Dis · February 9, 2025 Despite growing awareness that disclosing biomarker results to research participants is aligned with ethical principles of researcher-participant partnership, there are currently no widely adopted guidelines for this disclosure in Alzheimer's disease resea ... Full text Link to item Cite

Neuropsychiatric Comorbidities and Psychotropic Medication Use in Medicare Beneficiaries With Dementia by Sex and Race.

Journal Article J Geriatr Psychiatry Neurol · January 2025 BACKGROUND: Neuropsychiatric symptoms affect the majority of dementia patients. Past studies report high rates of potentially inappropriate prescribing of psychotropic medications in this population. We investigate differences in neuropsychiatric diagnoses ... Full text Link to item Cite
View All Publications

Recent Grants


Long-term Follow-up to Evaluate the Safety of LX1001 in Participants with APOE4 Homozygote Alzheimer's Disease.

Clinical TrialPrincipal Investigator · Awarded by LEXEO Therapeutics, Inc · 2024 - 2029

Biopsy-based single cell assays for olfactory sensory changes in an Alzheimer's Disease cohort

ResearchCo Investigator · Awarded by National Institute on Aging · 2024 - 2028

Automated High-purity Exosome isolation-based AD diagnostics system (AHEADx)

ResearchCo-Principal Investigator · Awarded by National Institute on Aging · 2023 - 2028

View All Grants

Education, Training & Certifications


University of Pittsburgh, School of Medicine · 1999 M.D.